Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21032)

• Formulation Name: Thalidomide 200 mg capsule
• Company: Celgene Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Thalidomide	(DM70BU5)	Adult T-cell leukemia/lymphoma		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant